Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $98.17 which represents a slight increase of $1.28 or 1.32% from the prior close of $96.89. The stock opened at $97.03 and ...
Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...
In August, a single email triggered a chain of hand-wringing and strategizing inside one of America’s largest medical technology companies: A reporter asked Boston Scientific if the biotech ...
In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price ...
9d
The agreement strengthens Boston Scientific's Position in Minimally Invasive Treatment for Coronary Artery Disease ...
That makes EPS growth an attractive quality for any company. Boston Scientific managed to grow EPS by 16% per year, over three years. That growth rate is fairly good, assuming the company can keep ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback